February 11, 2015
In this transcript, Dr. Bullock talks about the CAP protocol for examining specimens from patients with thyroid cancer
Read the transcript of Dr. Martin Bullock’s talk about the newest 2014 CAP protocol for examining specimens from patients with carcinomas in the thyroid gland. He also talks about changes to the protocol from its prior iteration in June 2012 and practical applications for recording the Cancer Case Summary components.
Martin Bullock, MD, FRCPC graduated in 1988 from Memorial University Medical School in St. John’s, Newfoundland, Canada. After a two-year stint of general practice in Ottawa, Ontario, he trained in Anatomical Pathology at the University of Toronto in Ontario, graduating in 1995. He completed a Forensic Pathology fellowship at the University of Maryland in Baltimore, Maryland, U.S.A and practised in Forensic Pathology for two years in Toronto. In 1988, he went into a full-time Surgical Pathology practice at QEII Health Sciences Centre in Halifax, Nova Scotia. There he practised Head and Neck Pathology and Cytopathology as a Full Professor of Pathology at Dalhousie University Medical School, with a cross appointment in the Division of Otolaryngology. Dr. Bullock is also a member of the Partnership’s National Pathology Standards Committee.
The Partnership, the Canadian Association of Pathologists (CAP-ACP) and Cancer Care Ontario (CCO) have organized this College of American Pathologists (CAP) education session.
In July 2009, the CAP-ACP endorsed the cancer protocols developed by CAP as the Canada-wide standard for all cancer-pathology reporting. To date, CAP protocols have been implemented in six Canadian provinces with the CAP-ACP’s support.
The protocols help pathologists to report effectively about diagnostic and prognostic findings, which are critical to patient care and the collection of collaborative stage data. The protocols were developed by multidisciplinary teams and are supported by CAP in both paper and electronic formats.